Heptane-extractable fractions (HEF) prepared from immune-activated macrophages (IA-M) of tubercle bacilli or bovine gamma globulin-sensitized and -challenged guinea pigs inhibited the growth of tubercle bacilli whereas HEF of normal macrophages exerted no antibacterial activity. In distinction to the strong antibacterial activity of HEF of IA-M, HEF of immune macrophages exerted weak or no antimycobacterial activity. HEF of alveolar macrophages exerted stronger antibacterial activity than HEF of peritoneal macrophages. The degree of the antibacterial activity of HEF was determined primarily by the time of macrophage collection from antigenically stimulated animals. The antibacterial activity gradually increased and peaked at 2 weeks after the antigenic stimulation of sensitized animals; subsequently, the activity declined and disappeared in about 5 weeks. Similar to other immunological reactions, the stimulation of sensitive animals with specific antigen induced an anamnestic reaction which was characterized by a rapid recall of the macrophage anti'mycobacterial phenomenon (MAP). The antibacterial strength of the recalled phenomenon in sensitized animals was dependent upon the intensity of the sensitizing regimen; the phenomenon was much stronger in three times-sensitized animals than in once-and twice-sensitized animals. The time of appearance and the specificity of induction and of recall of the MAP indicate that the phenomenon is associated with the activated state in macrophages and, as a consequence of this association, it has a well-defined immunological nature.
Heptane-extractable fractions (HEF) prepared from immune-activated macrophages (IA-M) of tubercle bacilli or bovine gamma globulin-sensitized and -challenged guinea pigs inhibited the growth of tubercle bacilli whereas HEF of normal macrophages exerted no antibacterial activity. In distinction to the strong antibacterial activity of HEF of IA-M, HEF of immune macrophages exerted weak or no antimycobacterial activity. HEF of alveolar macrophages exerted stronger antibacterial activity than HEF of peritoneal macrophages. The degree of the antibacterial activity of HEF was determined primarily by the time of macrophage collection from antigenically stimulated animals. The antibacterial activity gradually increased and peaked at 2 weeks after the antigenic stimulation of sensitized animals; subsequently, the activity declined and disappeared in about 5 weeks. Similar to other immunological reactions, the stimulation of sensitive animals with specific antigen induced an anamnestic reaction which was characterized by a rapid recall of the macrophage anti'mycobacterial phenomenon (MAP). The antibacterial strength of the recalled phenomenon in sensitized animals was dependent upon the intensity of the sensitizing regimen; the phenomenon was much stronger in three times-sensitized animals than in once-and twice-sensitized animals. The time of appearance and the specificity of induction and of recall of the MAP indicate that the phenomenon is associated with the activated state in macrophages and, as a consequence of this association, it has a well-defined immunological nature.
The parallel development of increased enzymatic and bactericidal effects in immunologically activated macrophages suggested that the defense mechanism of immune host against facultative intracellular parasites may depend upon the enzymatic degradation of the parasites in phagocytic vacuoles. However, there is no well-substantiated evidence to suggest that lysosomal enzymes exert a direct antibacterial effect and protect immune macrophages against parasitism with facultative intracellular bacterial pathogens. Several recent studies showed that cell-free extracts of spleen, liver, or lung tissues have antibacterial activity; extracts prepared from tissue cells of immunologically stimulated animals exerted much stronger antibacterial effects than tissue cell extracts of normal animals (2, 3, 8, 11) . These antibacterial effects of tissue extracts were attributed to antibacterial activity of non-esterified fatty acids. Some of the findings indicated that the antibacterial effect was associated to a large extent with cell membranes which produce free fatty acids by the hydrolysis of lipoidal materials by membrane-bound lipases (11).
Since animal tissues are composed of various cells, it is not possible to identify the cell type responsible for the antibacterial activity of tissue extracts. Therefore, we restricted our investigation to macrophages and tested lysates or heptane-extractable fractions (HEF) prepared from the same number of normal (N), immune (I), and immune-activated (IA) macrophages (M) for antimycobacterial activity (10) . The shift from tissue cells to known number of M permitted the quantitation of the macrophage antimycobacterial phenomenon (MAP) and the association of the phenomenon with the effector cell of cellular immunity. This study has shown that HEF of I-M exerted antimycobacterial effects, whereas HEF of N-M were inactive. The increased formation of antibacterial factors during an incubation of M lysates, their solubility in heptane, the neutralization of their toxicity with albumin, and other characteristics suggested that the antimycobacterial effect was exerted by free fatty acids. Various experiments with M of BCG-and bovine gamma globulin (BGG)-sensitized animals suggested that MAP was associated with delayed KOCHAN AD hypersensitivity and immunological activation of M.
The study reported in this communication shows that the demonstration of MAP is dependent upon the time of M collection and its antibacterial strength is determined by the intensity of the sensitizing procedure. These characteristics, as well as the well-defined anamnestic response elicited in sensitized animals with specific antigens, suggest that MAP is the product of immunological responses which take place in stimulated macrophages. 10 mg of the protein per 1 ml of the solution. Usually the sensitizing regimen with these two antigens consisted of three injections administered at 2-week intervals. One month after the last dose of antigen, guinea pigs were either sacrificed to obtain I-M or immunologically restimulated (challenged) with specific antigens; BCGsensitized animals were injected intravenously with 3.0 mg of heat-killed BCG cells suspended in 1 ml of saline solution and BGG-sensitized animals were injected intraperitoneally with 0.1 mg of BGG solubilized in 1 ml of saline solution. In this and other similar studies (6, 14) , the resensitized animals served as donors of IA-M which were collected 3 days after the resensitizing treatment.
MATERIALS AND METHODS
Tests for the presence of delayed hypersensitivity in sensitized guinea pigs were performed by intradermal injection of a specific antigen into the flanks of the animals. Guinea pigs vaccinated with BCG were injected with 0.1 ml of 1:10 dilution of old tuberculin (OT, 4 times U.S. Standard, Lederle Laboratories) and BGG-sensitized animals were injected with 0.1 ml of saline containing 0.1 mg of BGG. The evaluation of delayed hypersensitivity was done 24 and 48 h after the injection of antigens by grading the reactions according to the diameter and thickness of induration and the diameter of necrosis (9) .
Collection of M. M were harvested from normal and immune guinea pigs by washing the peritoneal cavities and pulmonary alveoli with 35 ml of Hanks D GOLDEN INFECT. IMMUNITY balanced salt solution containing 5 U of heparin per 1 ml of the fluid. PM were collected by the method described by Kochan and Smith (12) and AM by a method of Myrvik and associates (16) , which was adjusted to the use in guinea pigs (10) . The peritoneal and alveolar washings were centrifuged for 20 min at 800 x g (Sorvall, RC2-B centrifuge), the supernatant fluids were decanted, and the cell buttons were resuspended in phosphate-buffered sucrose (pH 6.6; 0.25 M) to a concentration of 2 x 107 M/ml of the fluid. The suspensions contained about 80 to 90% of M; the contaminating cells were primarily lymphocytes. Preparation of HEF. M lysates were prepared by subjecting N-M, I-M, and IA-M (2 x 107 M/ml of phosphate-buffered sucrose) to 10 successive freezethaw cycles. The progress and the completion of cell and lysosome disintegration was determined by microscope examination of stained samples. Since previous results showed a progressive increase in the degree of antimycobacterial activity and the amount of non-esterified antibacterial fatty acids during a 5-day incubation period (10, 11) , M lysates were incubated for 3 days at 37 C. All manipulations with cells and lysates were done aseptically; the growth of an occasional contaminant during the 3-day incubation period was prevented by the use of 100 U of penicillin and 50 ,g of streptomycin per 1 ml of M lysate. After the incubation period, the lysates were combined in a 1:5 ratio with the mixture of isopropanol-heptane-2 N sulfuric acid (40:10:1). After 10 min, 2 ml of heptane and 3 ml of distilled water were added to each 6 ml of extraction sample. The upper heptane layer (2.5 ml), which contained antibacterial factors but no heptane-insoluble antibiotics, was collected and evaporated under a stream of nitrogen at 56 C. The dried material was dissolved in Hanks solution containing 60% ethyl alcohol which facilitated solubilization of the heptane-extractable lipoidal material. The antimycobacterial effects of various HEF were determined by testing their activities with the agarplate diffusion test.
Antimycobacterial assay. The agar-plate diffusion test was performed in plastic petri dishes (No. 3002, Falcon Plastic) filled with Dubos agar medium adjusted to 0.5 mg of bovine albumin per 1 ml of the medium and pH of 7.5. The plates for the agar-plate diffusion test were prepared aseptically by several well-controlled steps (10) . In short, the plates received 2 ml of the medium; after its solidification, wells (1 cm in diameter) were made in the center of the plates by putting a siliconized glass cylinder on the prepared layer of the medium and adding to the plate 10 ml more of the same medium. The glass cylinders were removed from the gelled medium, and prepared wells were filled with 0.4 ml of HEF previously reconstituted in the Hanks solution-alcohol mixture. During the 24-h diffusion of the test materials from the well into the surrounding medium, the antibacterial effect of alcohol was eliminated by dilution and evaporation; the poorly water-soluble lipoidal materials with antimycobacterial effect were deposited around the wells in the gelled medium. After the diffusion period, the glass cylinders were (0) or one-, two-, and three-times BCG-vaccinated guinea pigs.
The influence of the sensitizing regimen on the level of MAP formation was determined by the evaluation of antimycobacterial activities of HEF prepared from AM and PM harvested from animals subjected to the BCG resensitization 1 month after one, two, and three BCG vaccinations. Results (Fig. 1) show quite clearly that the effectiveness by which various HEF inhibited bacillary growth was determined by the intensity of sensitizing regimen. The MAP elicited by the resensitization of three-timesvaccinated animals was stronger than that elicited by the identical resensitization of twotimes-vaccinated animals and much stronger than that of one-time-vaccinated animals. HEF prepared from M of unvaccinated but resensitizing dose-treated animals exerted no (PM) or weak (AM) antimycobacterial activity. Similar to previous results, the pictures in Fig. 1 show that the antimycobacterial activity exerted by HEF of AM is constantly and significantly stronger than that exerted by HEF of PM.
The duration of MAP in sensitized animals was determined by testing HEF, prepared from M collected 1, 2, 3, 4, and 5 weeks after the third BCG vaccination, for antimycobacterial activity (Table 2) . Results showed that the strength of HEF antibacterial activity increased during 2 weeks after the vaccination; after this period of MAP potentiation, the antimycobacterial activity progressively decreased and disappeared at the 5-week testing. Results ( Table 2 ) show also that, 5 weeks after the vaccination when MAP was not detectable in HEF, the strong antimycobacterial activity can be recalled quickly by the injection of sensitized animals with the specific antigenic material. Similar antigenic stimulation of normal animals did not induce a demonstrable antimycobacterial response (see Table 1 and Fig. 1 ). Three days after the resensitization of animals, the strength of the recalled MAP in their M exceeded that which was present in M harvested from animals 2 weeks after the vaccination regimen (Table 3 ). The recalled MAP retained its antimycobacterial strength for about 1 week; then it gradually declined, and, at 4 weeks after the resensitization, the HEF exerted only a weak antibacterial activity. The limited duration of MAP in sensitized and resensitized animals indicates that the time for M collection in the study of MAP is (10) that the antimycobacterial activity in lysates of activated M is exerted by non-esterified fatty acids whose amount increases to a demonstrable toxic level during the 3-day incubation period. Attempts to demonstrate antibacterial activity in unincubated lysates were not successful. Since we have shown that free fatty acids in M lysates originate mainly in cell wall materials during decomposition of phospholipids with cell wall-bound lipases (11) , it is possible that the presence of the antibacterial activity in M lysates is determined by the amount of cell wall materials. Big IA-M contain more cell wall material and consequently their lysates produce more fatty acids than the corresponding lysates of small normal cells. The presence of bactericidal levels of free fatty acids in serum of immunologically stressed animals (I. Kochan and M. Berendt, J. Infect. Dis., in press) shows that the production of fatty acids from materials of IA-M is not limited to a test tube. Our preliminary results show that the antibacterial fatty acids are formed in animals from materials of killed hypersensitive M. It has been found by other investigators that M died at the highest rate in secondary tuberculous lesions at the time period when delayed hypersensitivity and M activation were at the peak of their reactivity (1) . In light of these findings, it is not unreasonable to suggest that the antibacterial effect in vaccinated animals is due to the production of antibacterial fatty acids by materials of dead M rather than to the activity of living activated M.
This study shows that the MAP can be induced in delayed hypersensitive animals in response to the stimulation with homologous, but not heterologous, antigen. This requirement for the specific antigenic stimulation in the induction of MAP indicates that the phenomenon is associated with immunological responses elicited in sensitive animals with specific antigens. The induction or potentiation of MAP by antigens other than those of mycobacterial origin suggest that the phenomenon represents a general response of sensitive cells to specific antigenic stimulation. The specificity of the induction and the requirement for the presence of delayed hypersensitivity make the MAP related to cellular immunity which, in spite of its nonspecific nature, is specifically induced or recalled and requires delayed hypersensitivity for its existence (15) . The relationship of MAP with immune reactivities is also indicated by the correlation between the intensity of antigenic stimulation and the degree of antibacterial activity in HEF of M lysates. The results show that the strength of antimycobacterial activity of HEF varied in M of resensitized animals according to the number of previous vaccinations; after each additional BCG vaccination, the resensitization elicited stronger antimycobacterial effect in M of treated animals. The results show that MAP is short in duration and disappears in about 4 weeks. The recall of the subsided MAP at the strength corresponding to the number of vaccinations suggests that each additional vaccination enlarges immunological inemory in treated animals which potentiates the antibacterial response to specific antigen. This finding suggests that the mechanisms for M activation and for the formation of MAP are the same; both mechanisms depend on the presence of committed lymphocytes, which, when stimulated with specific antigen, produce M activating substances (13, 17) and products which induce in M the formation of materials with the potential to form antibacterial fatty acids. In light of this reasoning, we can conclude that the MAP is not produced in response to the direct antigenic stimulation of M; the MAP is the consequence of physiological changes which take place in M under the influence of antigen-induced lymphocytic mediators.
After the disappearance of MAP, it can be recalled rapidly in sensitized animals by the injection of specific antigen. When the peak of antimycobacterial activity in M of vaccinated animals occurred 14 days after the treatment, the peak after the restimulation was present in 3 days. The peak of MAP in restimulated animals was always higher than that in vaccinated animals. These findings show that MAP is quite similar to the well-known anamnestic response which is characterized by the rapid formation and the high titer of antibodies in animals subjected to the second antigenic stimulation. The specificity associated with the induction of MAP, all dose-and time-dependent requirements for the strong MAP elicitation, as well as the well-defined anamnestic response indicate that the phenomenon is related to immunological reactions.
VOL. 9, 1974 The persistence of MAP after the vaccination coincides with the duration of anti-Listeria immunity in BCG-vaccinated mice (14) . Similar to MAP time course, this nonspecific immunity peaked in 2 weeks and nearly disappeared 4 weeks after the vaccination. The duration of MAP and the duration of resistance to nonspecific infectious agents for the same time period in BCG-vaccinated animals suggest that the described phenomenon may be responsible for the protection of vaccinated host against bacterial parasites. The wide spectrum of antibacterial activity of MAP-determining fatty acids may account for the nonspecific nature of the antibacterial activity of activated M. The M activity seems not to be limited to antibacterial effects; recent experiments indicate that activated M in BCG-stimulated animals may possess suppressive effects on experimental neoplasms (4, 7) . It has been shown that fatty acids, which we find in association with activated M (10, 11), exert antitumor effects in in vitro and in vivo experiments (5, 18) . It is possible, therefore, that the mechanism of the antimycobacterial and antitumor activity in BCG-treated animals could be attributed to the formation of toxic levels of fatty acids from M materials in pathological lesions of sensitized animals.
